Plain-English translation of NCT06507787 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a blood test called EDIT-B® that may help doctors tell the difference between major depression and bipolar disorder—two conditions that look similar but need different treatments. About half of the participants will have their doctors use the blood test results to guide treatment decisions, while the other half will receive standard care. The study wants to see if using this blood test helps patients get better treatment faster and improve their health outcomes.
Many people with bipolar disorder are mistakenly treated like they have regular depression, which can actually make their condition worse and increase suicide risk. On average, people wait about 7 years for a correct bipolar diagnosis. This trial exists to see if a blood test can speed up the right diagnosis and get people the correct treatment sooner.
You likely qualify if…
You likely don't qualify if…
You will come in for 4 visits over 6 months. At the start, you'll have a blood test and complete an assessment of your depression symptoms. Depending on which group you're assigned to, your doctor may or may not use the blood test results to decide on your treatment—but either way, you'll be monitored to see how well your treatment is working. The study team will follow up with you to track your progress and see whether the blood test helped guide better care.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France